Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis
NCT ID: NCT00488176
Last Updated: 2013-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
116 participants
INTERVENTIONAL
2007-04-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED)
NCT00968149
Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)
NCT00974571
The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)
NCT00092118
Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)
NCT00972738
Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)
NCT00963599
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to compare the effect of montelukast and cetirizine on allergic inflammation measured by exhaled nitric oxide concentration in children with seasonal allergic rhinitis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
monteluksat sodium
montelukast
montelukast sodium
2
cetirizine
cetirizine
cetirizine
3
montelukast sodium and cetirizine
montelukast and cetirizine
montelukast and cetirizine
4
placebo
placebo
placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
montelukast
montelukast sodium
cetirizine
cetirizine
montelukast and cetirizine
montelukast and cetirizine
placebo
placebo
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* allergy to perennial allergens
* specific immunotherapy
* other chronic diseases
* tobacco smoking
* acute respiratory tract infection
* excluded drugs: inhaled and systemic glucocorticosteroids
6 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Lodz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Iwona Stelmach
MD, PhD, Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Violetta Ścibiorek, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Pediatrics and Allergy, Medical University of Lodz, Poland
Iwona Stelmach, MD PhD Prof
Role: STUDY_CHAIR
Department of Pediatrics and Allergy, Medical University of Lodz, Poland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Pediatrics and Allergy, Medical University of Lodz Lodz, Poland
Lodz, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RNN/94/07KE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.